サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1289007

臨床診断の世界市場

Clinical Diagnostics: Global Markets
出版日: | 発行: BCC Research | ページ情報: 英文 111 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
臨床診断の世界市場
出版日: 2023年06月07日
発行: BCC Research
ページ情報: 英文 111 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床診断の市場規模は、2022年の678億米ドル、2023年の731億米ドルから、2023年から2028年にかけての予測期間中は7.2%のCAGRで推移し、2028年には1,034億米ドルの規模に成長すると予測されています。

脂質パネルの部門は、2023年の281億米ドルから、7.5％のCAGRで推移し、2028年には403億米ドルの規模に成長すると予測されています。また、感染症検査の部門は、2023年の195億米ドルから、7.8%のCAGRで推移し、2028年には284億米ドルの規模に成長すると予測されています。

当レポートでは、世界の臨床診断の市場を調査し、市場および技術の背景、市場影響因子の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、新興技術の分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場および技術の背景

  • 概要
  • 品質管理
  • 品質保証
  • ターンアラウンドタイム
  • 臨床的相関関係
  • 精度と信頼性
  • 患者の安全
    • 癌検診
    • 新生児スクリーニング
    • 感染症スクリーニング
    • 心血管疾患のスクリーニング
  • スクリーニングのタイプ
  • スクリーニング検査
  • スクリーニングガイドライン
  • スクリーニングのメリット
  • スクリーニングの制限
  • 遺伝子検査
  • 薬理ゲノミクス
  • バイオマーカー検査
  • プロテオミクス
  • メタボロミクス

第4章 臨床診断市場の内訳：検査タイプ別

  • 脂質パネル
  • 感染症検査
  • 全血球計算
  • 代謝パネル検査
  • 異常な代謝パネルの結果
  • その他のテスト

第5章 臨床診断市場の内訳：製品タイプ別

  • アッセイ・キット
  • 機器
  • 試薬
  • ソフトウェア・サービス

第6章 臨床診断市場の内訳：用途別

  • 感染症
  • 癌
    • 癌のタイプ
    • 癌の原因
    • 癌の症状
    • 癌の診断
    • 癌の治療
  • 循環器疾患

第7章 臨床診断市場の内訳：エンドユーザー別

  • 診断ラボ
  • 病院・診療所
  • その他

第8章 臨床診断市場の内訳：地域別

  • 世界市場の規模・予測
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第9章 市場力学

  • 市場促進要因
  • 市場の課題

第10章 新興技術

  • 分子診断
  • 次世代シーケンシング（NGS）
  • ポイントオブケア検査
  • AI
  • その他

第11章 競合情勢

第12章 企業プロファイル

  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX S.A.
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN N.V.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.
図表

List of Tables

  • Summary Table A : Global Market for Clinical Diagnostics, by Type of Test, Through 2028
  • Summary Table B : Global Market for Clinical Diagnostics, by Region, Through 2028
  • Table 1 : Global Market for Clinical Diagnostics, by Type of Test, Through 2028
  • Table 2 : Global Market for Clinical Diagnostics, by Product Type, Through 2028
  • Table 3 : Global Market for Clinical Diagnostics, by Application, Through 2028
  • Table 4 : Global Market for Clinical Diagnostics, by End User, Through 2028
  • Table 5 : Global Market for Clinical Diagnostics, by Region, Through 2028
  • Table 6 : North American Market for Clinical Diagnostics, by Country, Through 2028
  • Table 7 : European Market for Clinical Diagnostics, by Country, Through 2028
  • Table 8 : Asia-Pacific Market for Clinical Diagnostics, by Country, Through 2028
  • Table 9 : RoW Market for Clinical Diagnostics, by Sub-region, Through 2028
  • Table 10 : Abbott Diagnostics: Product Portfolio
  • Table 11 : Becton, Dickinson and Co.: Company Financials, 2022
  • Table 12 : Becton, Dickinson and Co.: Product Portfolio
  • Table 13 : bioMerieux SA: Product Portfolio
  • Table 14 : Bio-Rad Laboratories Inc.: Company Financials, 2022
  • Table 15 : Bio-Rad Laboratories Inc.: Product Portfolio
  • Table 16 : Danaher Corp.: Company Financials, 2022
  • Table 17 : Danaher Corp.: Product Portfolio
  • Table 18 : F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Table 19 : Qiagen: Product Portfolio
  • Table 20 : Siemens Healthineers AG: Product Portfolio

List of Figures

  • Summary Figure A : Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
  • Summary Figure B : Global Market for Clinical Diagnostics, by Region, 2020-2028
  • Figure 1 : Global Market for Clinical Diagnostics, by Type of Test, 2020-2028
  • Figure 2 : Global Market for Clinical Diagnostics, by Product Type, 2020-2028
  • Figure 3 : Global Market for Clinical Diagnostics, by Application, 2020-2028
  • Figure 4 : Global Market for Clinical Diagnostics, by End User, 2020-2028
  • Figure 5 : Global Market for Clinical Diagnostics, by Region, 2020-2028
  • Figure 6 : North American Market for Clinical Diagnostics, by Country, 2020-2028
  • Figure 7 : European Market for Clinical Diagnostics, by Country, 2020-2028
  • Figure 8 : Asia-Pacific Market for Clinical Diagnostics, by Country, 2020-2028
  • Figure 9 : RoW Market for Clinical Diagnostics, by Sub-region, 2020-2028
  • Figure 10 : Projected Worldwide Rate of Incidence of Diabetes in Patients Aged 20 to 79 Years, 2010 and 2030
  • Figure 11 : Abbott Laboratories: Diagnostics Division, Net Revenue, 2020-2022
  • Figure 12 : Abbott Diagnostics: Market Share, by Business Segment, 2022
  • Figure 13 : Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2022
  • Figure 14 : Becton, Dickinson and Co.: Revenue Share, by Region, 2022
  • Figure 15 : bioMerieux SA: Net Annual Revenue, 2020-2022
  • Figure 16 : bioMerieux SA: Market Share, by Application, 2022
  • Figure 17 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Segment, 2022
  • Figure 18 : Bio-Rad Laboratories Inc.: Revenue Share, by Region, 2022
  • Figure 19 : Danaher Corp.: Revenue Share, by Business Segment, 2022
  • Figure 20 : Danaher Corp.: Revenue Share, by Region, 2022
  • Figure 21 : F. Hoffmann-La Roche Ltd.: Diagnostics Division, Net Revenue, 2020-2022
  • Figure 22 : F. Hoffmann-La Roche Ltd.: Diagnostics Division, Market Share, by Customer Area, 2022
  • Figure 23 : Qiagen: Net Revenue, 2020-2022
  • Figure 24 : Qiagen: Market Share, by Product Type, 2022
  • Figure 25 : Siemens Healthineers AG: Net Revenue, 2020-2022
  • Figure 26 : Siemens Healthineers AG: Market Share, by Business Segment, 2022
  • Figure 27 : Thermo Fisher Scientific Inc.: Annual Revenue, 2020-2022
  • Figure 28 : Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2022
目次
Product Code: BIO243A

Highlights:

The global market for clinical diagnostics reached $67.8 billion in 2022. The market is estimated to grow from $73.1 billion in 2023 to reach $103.4 billion by 2028, at a compound annual growth rate (CAGR) of 7.2% from 2023 through 2028.

The lipid panel segment of the global clinical diagnostics market is estimated to grow from $28.1 billion in 2023 to reach $40.3 billion by 2028, at a CAGR of 7.5% from 2023 through 2028.

The infectious disease testing segment of the global clinical diagnostics market is estimated to grow from $19.5 billion in 2023 to reach $28.4 billion by 2028, at a CAGR of 7.8% from 2023 through 2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for clinical diagnostics, both quantitative and qualitative data, to help executives develop corporate growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics.

An in-depth market analysis includes historical data and market projections on sales by type of test, product type, application, end user and region. It describes the different types of clinical diagnostic tests and their current and historical market revenues. This report also categorizes the global clinical diagnostic market based on four geographic regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW).

For a more in-depth understanding of the market, the report provides profiles of leading companies and their respective market shares.

Report Includes:

  • 22 data tables
  • An up-to-date overview and analysis of the global clinical diagnostics market
  • Analyses of the global market trends, with historic market revenue data (sales figures) from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion of the major growth drivers, opportunities and challenges, technology updates, and the impact of macroeconomic variables influencing the market for clinical diagnostics as a basis for projecting demand in the next few years (2023-2028)
  • Estimation of the actual market size and revenue forecast for global clinical diagnostics market, and corresponding market share analysis based on the type of test, product and service, application, end user, and region
  • In-depth information (facts and figures) concerning the major market dynamics, screening tools and techniques, regulatory developments, new and emerging technologies, and current competitive landscape of the clinical diagnostic market
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Siemens Healthineers, Roche Diagnostics, Qiagen and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • 1.1 Improved Patient Outcomes
  • 1.2 Improved Public Health
  • 1.3 Reduced Healthcare Costs
  • 1.4 Study Goals and Objectives
  • 1.5 Reasons for Doing the Study
  • 1.6 Scope of Report
  • 1.7 Methodology and Information Sources
  • 1.8 Geographic Breakdown
  • 1.9 Analyst's Credentials
  • 1.10 BCC Custom Research
  • 1.11 Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • 3.1 Overview
  • 3.2 Quality Control
  • 3.3 Quality Assurance
  • 3.4 Turnaround Time
  • 3.5 Clinical Correlation
  • 3.6 Accuracy and Reliability
  • 3.7 Patient Safety
    • 3.7.1 Cancer Screening
    • 3.7.2 Newborn Screening
    • 3.7.3 Infectious Disease Screening
    • 3.7.4 Cardiovascular Disease Screening
  • 3.8 Types of Screening
  • 3.9 Screening Tests
  • 3.10 Screening Guidelines
  • 3.11 Benefits of Screening
  • 3.12 Limitations of Screening
  • 3.13 Genetic Testing
  • 3.14 Pharmacogenomics
  • 3.15 Biomarker Testing
  • 3.16 Proteomics
  • 3.17 Metabolomics

Chapter 4 Clinical Diagnostics Market Breakdown by Type of Test

  • 4.1 Introduction
    • 4.1.1 Lipid Panels
    • 4.1.2 Infectious Disease Testing
    • 4.1.3 Complete Blood Count
    • 4.1.4 Metabolic Panel Testing
    • 4.1.5 Abnormal Metabolic Panel Results
    • 4.1.6 Other Tests

Chapter 5 Clinical Diagnostics Market Breakdown by Product Type

  • 5.1 Introduction
  • 5.2 Assays and Kits
    • 5.2.1 Types of Assays and Kits in Clinical Diagnostics
  • 5.3 Instruments
    • 5.3.1 Types of Instruments
  • 5.4 Reagents
    • 5.4.1 Types of Reagents
  • 5.5 Software and Services
    • 5.5.1 Data Management

Chapter 6 Clinical Diagnostics Market Breakdown by Application

  • 6.1 Introduction
  • 6.2 Infectious Diseases
  • 6.3 Cancer
    • 6.3.1 Types of Cancer
    • 6.3.2 Causes of Cancer
    • 6.3.3 Symptoms of Cancer
    • 6.3.4 Diagnosis of Cancer
    • 6.3.5 Treatment of Cancer
  • 6.4 Cardiovascular Disease

Chapter 7 Clinical Diagnostics Market Breakdown by End User

  • 7.1 Introduction
  • 7.2 Diagnostic Laboratories
  • 7.3 Hospitals and Clinics
  • 7.4 Other End Users

Chapter 8 Clinical Diagnostics Market Breakdown by Region

  • 8.1 Introduction
  • 8.2 Global Market Size and Forecast
  • 8.3 North America
    • 8.3.1 United States
    • 8.3.2 Canada
  • 8.4 Europe
    • 8.4.1 Germany
    • 8.4.2 United Kingdom
  • 8.5 Asia-Pacific
  • 8.6 Rest of the World

Chapter 9 Market Dynamics

  • 9.1 Market Drivers
    • 9.1.1 Advances in Technology
    • 9.1.2 Increasing Prevalence of Chronic and Infectious Diseases
    • 9.1.3 Autoimmune Disorders
    • 9.1.4 Aging Population
    • 9.1.5 Rising Healthcare Expenditures
    • 9.1.6 Point-of-Care Testing
    • 9.1.7 Personalized Medicine
  • 9.2 Market Challenges
    • 9.2.1 Stringent Regulatory Scenario
    • 9.2.2 Reimbursement Challenges
    • 9.2.3 Increasing Market Competition

Chapter 10 Emerging Technologies

  • 10.1 Molecular Diagnostics
  • 10.2 Next-Generation Sequencing (NGS)
  • 10.3 Point-of-Care Testing
  • 10.4 Artificial Intelligence (AI)
  • 10.5 Other Emerging Techniques

Chapter 11 Competitive Landscape

  • 11.1 Overview

Chapter 12 Company Profiles

  • ABBOTT LABORATORIES
  • BECTON, DICKINSON AND CO.
  • BIOMERIEUX S.A.
  • BIO-RAD LABORATORIES INC.
  • DANAHER CORP.
  • F. HOFFMANN-LA ROCHE LTD.
  • QIAGEN N.V.
  • SIEMENS HEALTHINEERS AG
  • THERMO FISHER SCIENTIFIC INC.